PPB recalls Benylin Pediatric cough syrup due to safety concerns
KENYA—The Pharmacy and Poisons Board (PPB), Kenya’s drug regulator, has announced the recall of...
Read More
Tag: Johnson & Johnson
Johnson & Johnson sets sights on 20 drug launches amidst Stelara patent pressures
USA — Johnson & Johnson has set an ambitious goal, aiming to introduce a minimum of 20 new...
Read More
Johnson & Johnson MedTech invests US$400 million in cutting-edge device to address atrial fibrillation complications
USA – Johnson & Johnson MedTech has disclosed a substantial upfront investment of US$400...
Read More
Johnson & Johnson takes steps to make tuberculosis drug more accessible in Low- and Middle-Income Countries
USA — Johnson & Johnson (J&J) recently made a significant announcement, revealing its...
Read More
Johnson & Johnson faces investigation for allegedly overpricing critical tuberculosis drug in South Africa
SOUTH AFRICA —Pharmaceutical giant Johnson & Johnson (J&J), headquartered in the United...
Read More
South Africa’s COVID-19 vaccine contracts reveal disparities and risk assumptions
SOUTH AFRICA — An analysis of South Africa’s COVID-19 vaccine contracts has shed light on...
Read More
Neuromedicine startup Rapport Therapeutics secures US$150 million in Series B funding to propel clinical progress
USA — Rapport Therapeutics, a cutting-edge neuromedicine startup backed by Johnson & Johnson,...
Read More
Biosense Webster’s FDA approval paves the way for zero fluoroscopy workflow
USA —Biosense Webster, a distinguished entity within Johnson & Johnson MedTech has unveiled...
Read More
FDA greenlights Johnson & Johnson’s Akeega for BRCA-positive prostate cancer
USA — Johnson & Johnson has secured the coveted FDA approval for Akeega, a pioneering...
Read More
Johnson & Johnson names the new Managing Director of its medical device business in India
INDIA – Johnson & Johnson Private Limited has selected Anuj Virmani as the new Managing...
Read More
Johnson & Johnson foresees robust growth in 2023, bolstered by medical advancements and pharmaceutical portfolio
USA —Johnson & Johnson, a prominent healthcare conglomerate, is brimming with optimism as it...
Read More
Johnson & Johnson fights back to challenge the prescription price battle, claiming constitutional violations
USA — As the battle intensifies over a new law aimed at lowering prescription drug prices, Johnson...
Read More
LATEST DIGITAL MAGAZINE
